Customized Treatment Approach: The dosage and frequency of GLP-1 medications can be tailored to meet each patients specific needs and response to treatment
Substantial weight regain after discontinuation highlights the need to shift focus from short-term weight loss to long-term behavioral stabilization
Definition Retatrutide: A 39-amino-acid synthetic peptide that activates the GIP, GLP-1, and glucagon receptors simultaneously
Research from major clinical trials shows that participants who discontinued GLP-1 therapy regained an average of 5070% of their lost weight within 12 months
Prattichizzo F, de Candia P, De Nigris V, Nicolucci A, Ceriello A
Amino Meta is a chemical supplier and is not a compounding pharmacy or an outsourcing facility as defined under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act